The goal of this randomized study is to assess the impact on self-perceived quality of life (QoL) of systematic screening and early treatment of aftereffects in patients with gynaecological cancers. The main question it aims to answer is if systematic screening with validated questionaries (see in detailed description), diagnosis and early treatment of lower-limb lymphoedema, anxiety-depression, sexual dysfunction and sarcopenia-malnutrition all have a positive impact on the self-perceived QoL by gynaecological cancer patients. Participants will access the screening questionnaires and QoL questionaries on a free online app on their mobile devices. In the experimental group, in case of positive screening, patients will be referred to specialised care to early treatment of the aftereffects. Researchers will compare this group with standard usual care (opportunistic treatment) to see if systematic screening and early treatment lead to a better QoL.
Women aged ≥18 diagnosed with ovarian, tubal and primary peritoneal, cervical and endometrial cancer who are candidates for surgery during the study period.
Patients unable to complete by themselves the screening questionnaires included.
Parallel
systematic screening and early treatment
Diagnostic testin case of positive screening, the online app will alert and the patient will be referred to the corresponding area for diagnosis and early treatment (Rehabilitation, Psycho-oncology, Sexual health and Nutrition
Quality-of-life questionaries score
Unit on QLQ-C30 Quality-of-life scale
Quality-of-life questionaries score related to endometrial cancer
Unit on QLQ-EN-24 Quality-of-life scale
Quality-of-life questionaries score related to cervical cancer
Unit on QLQ-Cx-24 Quality-of-life scale
Quality-of-life questionaries score related to ovarian cancer
Unit on QLQ-Ov-28 Quality-of-life scale
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
